Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Y Lai

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Inflammatory Bowel Diseases|June 27, 2026
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel diseaseMahmud Hussain, Anne Y Lai, Derek Franklin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2023
Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human SpleenChunyan Wang, Anne Y Lai, Dana C Baiu, et al.
The Journal of Experimental Medicine|August 25, 2010
DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomasAnne Y Lai, Mehrnaz Fatemi, Archana Dhasarathy, et al.
Genome Research|September 10, 2013
DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activationAnne Y Lai, Deepak Mav, Ruchir Shah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2022
Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2<sup>+</sup> T Cells in the Presence of Costimulation by CD28 or NKG2DAnne Y Lai, Arpita Patel, Faraha Brewer, et al.
Journal for Immunotherapy of Cancer|October 2, 2020
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapyAnne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Inflammatory Bowel Diseases|June 27, 2026
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel diseaseMahmud Hussain, Anne Y Lai, Derek Franklin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2023
Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human SpleenChunyan Wang, Anne Y Lai, Dana C Baiu, et al.
The Journal of Experimental Medicine|August 25, 2010
DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomasAnne Y Lai, Mehrnaz Fatemi, Archana Dhasarathy, et al.
Genome Research|September 10, 2013
DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activationAnne Y Lai, Deepak Mav, Ruchir Shah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2022
Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2<sup>+</sup> T Cells in the Presence of Costimulation by CD28 or NKG2DAnne Y Lai, Arpita Patel, Faraha Brewer, et al.
Journal for Immunotherapy of Cancer|October 2, 2020
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapyAnne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, et al.
Pageof 2